Foresite Capital Management IV as of Sept. 30, 2019
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 17 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Turning Point Therapeutics I | 22.2 | $69M | 1.8M | 37.60 | |
| Aerie Pharmaceuticals | 9.9 | $31M | 1.6M | 19.22 | |
| Insmed (INSM) | 8.2 | $25M | 1.4M | 17.64 | |
| Medicines Company | 7.7 | $24M | 478k | 50.00 | |
| Ascendis Pharma A S (ASND) | 7.6 | $24M | 245k | 96.32 | |
| Cytokinetics (CYTK) | 7.0 | $22M | 1.9M | 11.38 | |
| Biohaven Pharmaceutical Holding | 5.7 | $18M | 426k | 41.72 | |
| Optinose (OPTN) | 5.1 | $16M | 2.2M | 7.00 | |
| Voyager Therapeutics (VYGR) | 4.6 | $14M | 831k | 17.21 | |
| Alector (ALEC) | 4.4 | $14M | 936k | 14.42 | |
| Myokardia | 4.0 | $12M | 238k | 52.15 | |
| Fulcrum Therapeutics (FULC) | 3.6 | $11M | 1.7M | 6.64 | |
| Cymabay Therapeutics | 3.4 | $11M | 2.1M | 5.12 | |
| Orchard Therapeutics Plc ads | 2.1 | $6.6M | 558k | 11.88 | |
| Rhythm Pharmaceuticals (RYTM) | 1.6 | $5.1M | 235k | 21.59 | |
| Immunomedics | 1.6 | $4.9M | 368k | 13.26 | |
| Si-bone (SIBN) | 1.2 | $3.6M | 206k | 17.67 |
